Ftse Mib
36.429,72
0,00%
DAX
21.727,20
0,48%
S&P 500
6.071,17
0,53%
NASDAQ
19.681,75
0,25%
Bitcoin
104.526,16
-0,20%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ FibroBiologics Inc (FBLG) FibroBiologics Inc (FBLG) Notizie

FibroBiologics Inc

FBLG
1,67
0,11 (7,05%)
31 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/1/202518:43EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
24/1/202522:05EDGAR2Form 8-K - Current report
22/1/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
17/1/202522:05EDGAR2Form POS AM - Post-Effective amendments for registration..
14/1/202522:34EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
10/1/202523:22EDGAR2Form S-1/A - General form for registration of securities..
31/12/202422:20EDGAR2Form 8-K - Current report
30/12/202422:30GLOBEFibroBiologics Closes Second $5 Million Tranche of $25..
30/12/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202420:12GLOBED. Boral Capital Served as Exclusive Placement Agent to..
30/12/202414:29EDGAR2Form S-1 - General form for registration of securities under..
23/12/202414:00EDGAR2Form 8-K - Current report
23/12/202413:55GLOBEFibroBiologics Announces $25 Million Financing
20/12/202423:15EDGAR2Form 8-K - Current report
19/11/202415:15GLOBEFibroBiologics Files Patent Application for a Cell-based..
14/11/202415:15GLOBEFibroBiologics Files Patent Application Covering Reduction..
12/11/202422:20GLOBEFibroBiologics Reports Third Quarter 2024 Financial Results..
12/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202421:01EDGAR2Form 8-K - Current report
29/10/202414:15GLOBEFibroBiologics Announces Updates for Novel Artificial Thymus..
28/10/202414:31GLOBEFibroBiologics to Present at the 2024 ThinkEquity Conference..
18/10/202414:30GLOBEFibroBiologics and Charles River Announce Collaboration to..
16/10/202415:15GLOBEFibroBiologics Issued Patent for Fibroblast Delivery of..
11/10/202415:31GLOBEFibroBiologics to Participate in a Fireside Chat at 2024..
30/9/202415:31GLOBEFibroBiologics to Present at 2024 Cell & Gene Meeting on the..
24/9/202422:01EDGAR2Form 8-K - Current report
19/9/202415:31GLOBEFibroBiologics Engages Southern Star Research as CRO in..
12/9/202415:31GLOBEFibroBiologics Announces Filing of Patent Application for..
06/9/202415:31GLOBEFibroBiologics to Present at the H.C. Wainwright 26th Annual..
28/8/202422:01EDGAR2Form 8-K - Current report
28/8/202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/8/202422:01EDGAR2Form 8-K - Current report
20/8/202415:31GLOBEFibroBiologics Announces Filing of Patent Application for..
13/8/202422:05EDGAR2Form POS AM - Post-Effective amendments for registration..
13/8/202403:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202400:52GLOBEFibroBiologics Files 2024 Second Quarter Report
07/8/202423:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/7/202415:31GLOBEFibroBiologics to Present at JonesTrading Healthcare Summit..
25/6/202415:31GLOBEFibroBiologics Announces Preliminary Proof of Concept for..
18/6/202422:12EDGAR2Form S-1 - General form for registration of securities under..
13/6/202415:31GLOBEFibroBiologics Set to Join Russell 2000® Index
06/6/202416:58EDGAR2Form RW - Registration Withdrawal Request
06/6/202415:31GLOBEFibroBiologics to Present at Extracellular Matrix..
04/6/202420:36EDGAR2Form S-1/A - General form for registration of securities..
15/5/202422:30GLOBEFibroBiologics Announces 2024 Annual Meeting of Stockholders
15/5/202422:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/5/202423:24GLOBEFibroBiologics Files 2024 First Quarter Report
14/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 1,74 Min: 1,55 Max: 1,74
Chiusura: 1,56

La tua Cronologia

NASDAQ
FBLG
FibroBiologics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci